160 related articles for article (PubMed ID: 11457548)
1. Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice.
Zheng BJ; Ng MH; He LF; Yao X; Chan KW; Yuen KY; Wen YM
Vaccine; 2001 Jul; 19(30):4219-25. PubMed ID: 11457548
[TBL] [Abstract][Full Text] [Related]
2. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B.
Wen YM; Qu D; Zhou SH
Int Rev Immunol; 1999; 18(3):251-8. PubMed ID: 10614727
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.
Oka Y; Akbar SM; Horiike N; Joko K; Onji M
Immunology; 2001 May; 103(1):90-7. PubMed ID: 11380696
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes.
Hui J; Mancini M; Li G; Wang Y; Tiollais P; Michel ML
Vaccine; 1999 Mar; 17(13-14):1711-8. PubMed ID: 10194827
[TBL] [Abstract][Full Text] [Related]
7. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
[TBL] [Abstract][Full Text] [Related]
8. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.
Kurose K; Akbar SM; Yamamoto K; Onji M
Immunology; 1997 Dec; 92(4):494-500. PubMed ID: 9497491
[TBL] [Abstract][Full Text] [Related]
9. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
10. Effect of plasmid DNA on immunogenicity of HBsAg-anti-HBs complex.
Qu D; Yuan ZH; He LF; Yang L; Li GD; Wen YM
Viral Immunol; 1998; 11(2):65-72. PubMed ID: 9765028
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
12. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
13. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional analysis of immune-related genes in dendritic cells from hepatitis B surface antigen (HBsAg)-positive transgenic mice and regulation of Fc gamma receptor IIB by HBsAg-anti-HBs complex.
Yao X; Wang XY; Zhao C; Sun SH; Meng ZF; Zhang JM; Xu JQ; Xie YH; Yuan ZH; Wen YM
J Med Virol; 2011 Jan; 83(1):78-87. PubMed ID: 21108342
[TBL] [Abstract][Full Text] [Related]
16. Nasal route favors the induction of CD4
Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML
Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155
[TBL] [Abstract][Full Text] [Related]
17. Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.
Heijtink RA; van Bergen P; Paulij WP; de Man RA; Osterhaus AD
Vaccine; 2000 Feb; 18(15):1531-8. PubMed ID: 10618551
[TBL] [Abstract][Full Text] [Related]
18. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
[TBL] [Abstract][Full Text] [Related]
19. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
20. Long-term persistence of hepatitis B surface antigen and antibody induced by DNA-mediated immunization results in liver and kidney lesions in mice.
Zi XY; Yao YC; Zhu HY; Xiong J; Wu XJ; Zhang N; Ba Y; Li WL; Wang XM; Li JX; Yu HY; Ye XT; Lau JT; Hu YP
Eur J Immunol; 2006 Apr; 36(4):875-86. PubMed ID: 16552712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
